NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
Advertisement
NewsRx | Free Trials
Advertisement
----------
------------
NewsRx on Facebook
-----
Press Release Submissions
PR Login
*
*

Drug Week

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Drug Week

Learn More

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now



Bioengineering



Affymax Names Robert F. Venteicher, Ph.D., Vice President, Technical Operations



August 31st, 2007

Affymax, Inc. (Nasdaq:AFFY) announced that Robert F. Venteicher, Ph.D. has joined the company as vice president, Technical Operations. Dr. Venteicher has nearly 30 years of experience in pharmaceutical and biotechnology drug development. In this position, Dr. Venteicher will oversee manufacturing and process development, quality and facility operations for Affymax.

Dr. Venteicher is experienced in managing supply chain and quality strategies for contracted and collaborative business alliances for development and commercial products sourced globally. His drug development experience includes work on vaccines, antibodies, recombinant proteins, toxins, small molecule...


Source: Drug Week (2007-08-31)

NewsRx Passes
Advertisement
More Articles

Related Topics

------------------------
Security by Verisign PR Login